University of Oxford at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
University of Oxford brings 12 presentations to ASH 2026 in New Orleans. Its research spans leukemia biology, sickle cell diagnostics and digital pathology. It includes a first-in-human trial of the menin inhibitor CHM-029 and a human multi-organoid platform.
| Organization | ASH 2026 Attendance |
|---|---|
University of Oxford Oxford, United Kingdom | |
Collegiate research university in Oxford, England. | Talk Fri Dec 11 5:18pm–5:58pm Session Fri Dec 11 5:18pm–5:58pm Digital Pathology in Diagnostic Hematology Machine learning that diagnoses blood cancers from digital images of biopsies and blood or marrow smears. Oral Sat Dec 12 2:00pm–3:30pm Oral Sun Dec 13 4:30pm–6:00pm Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Oral Mon Dec 14 4:30pm–6:00pm Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm |
Find decision makers at University of Oxford
Tell us what you sell and we’ll find the people at University of Oxford most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction